Unlocking the therapeutic potential of targeting MALT1 in B-cell acute lymphoblastic leukemia

被引：0
|
作者：
Samiksha [1 ]
Chan, Lai N. [1 ,2 ]
机构：
[1] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland Clin, Sch Med, Dept Mol Med,Lerner Coll Med, Cleveland, OH 44106 USA
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 05期
关键词：
D O I：
10.3324/haematol.2023.284237
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1317 / 1319
页数：3
相关论文
共 50 条
  • [21] CLINICAL, THERAPEUTIC, AND PROGNOSTIC ASPECTS OF ACUTE B-CELL LYMPHOBLASTIC-LEUKEMIA
    VASSAL, G
    LEVERGER, G
    SCHAISON, G
    CASTAIGNE, S
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1986, 28 (03): : 141 - 146
  • [22] Chemically Induced Degradation of MALT1 to Treat B-Cell Lymphomas
    Fontan, Lorena
    Hatcher, John
    Scott, David
    Qiao, Qi
    Us, Ilkay
    Du, Guangyan
    Durant, Matthew
    Wilson, Jimmy
    Wu, Hao
    Gray, Nathanael
    Melnick, Ari
    BLOOD, 2019, 134
  • [23] Targeting SF3B1 in High-Risk B-Cell Acute Lymphoblastic Leukemia
    Murakami, Yuki
    Konishi, Hiroaki
    Tepper, Cliff
    McPherson, John
    Satake, Noriko
    BLOOD, 2023, 142
  • [24] THERAPEUTIC POTENTIAL OF TARGETING SPHINGOSINE KINASES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Evangelisti, Cecilia
    ANTICANCER RESEARCH, 2014, 34 (10) : 5898 - 5899
  • [25] Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)
    Evangelisti, Camilla
    Evangelisti, Cecilia
    Chiarini, Francesca
    Lonetti, Annalisa
    Buontempo, Francesca
    Bressanin, Daniela
    Cappellini, Alessandra
    Orsini, Ester
    McCubrey, James A.
    Martelli, Alberto M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 909 - 918
  • [26] RUNX1 amplification in B-cell acute lymphoblastic leukemia
    De Braekeleer, Etienne
    Douet-Guilbert, Nathalie
    Morel, Frederic
    Le Bris, Marie-Josee
    Berthou, Christian
    Ferec, Claude
    De Braekeleer, Marc
    LEUKEMIA & LYMPHOMA, 2010, 51 (02) : 329 - 332
  • [27] Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia
    Tsao, L
    Draoua, HY
    Osunkwo, I
    Nandula, SV
    Murty, VVS
    Mansukhani, M
    Bhagat, G
    Alobeid, B
    MODERN PATHOLOGY, 2004, 17 (07) : 832 - 839
  • [28] Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia
    Fidyt, Klaudyna
    Pastorczak, Agata
    Goral, Agnieszka
    Szczygiel, Kacper
    Fendler, Wojciech
    Muchowicz, Angelika
    Bartlomiejczyk, Marcin Adam
    Madzio, Joanna
    Cyran, Julia
    Graczyk-Jarzynka, Agnieszka
    Jansen, Eugene
    Patkowska, Elzbieta
    Lech-Maranda, Ewa
    Pal, Deepali
    Blair, Helen
    Burdzinska, Anna
    Pedzisz, Piotr
    Glodkowska-Mrowka, Eliza
    Demkow, Urszula
    Gawle-Krawczyk, Karolina
    Matysiak, Michal
    Winiarska, Magdalena
    Juszczynski, Przemyslaw
    Mlynarski, Wojciech
    Heidenreich, Olaf
    Golab, Jakub
    Firczuk, Malgorzata
    MOLECULAR ONCOLOGY, 2019, 13 (05) : 1180 - 1195
  • [29] Targeting the p53 response in pediatric B-cell acute lymphoblastic leukemia
    Wolak, Kathryn E.
    Skol, Andrew
    Bainer, Russell
    Onel, Kenan
    CANCER RESEARCH, 2012, 72
  • [30] Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia
    Kotecha, Rishi S.
    Trinder, Sarah M.
    Hughes, Anastasia M.
    Mullin, Benjamin H.
    Rashid, Sarah
    Yuan, Jinbo
    Xu, Jiake
    Duncan, Owen
    Skut, Patrycja
    Chua, Grace-Alyssa
    Singh, Sajla
    Oommen, Joyce
    Lock, Richard B.
    Kees, Ursula R.
    Malinge, Sebastien
    Kuek, Vincent
    Cheung, Laurence C.
    BLOOD CANCER JOURNAL, 2025, 15 (01):
12345